T. Van Staa

First name
T.
Last name
Van Staa
Pate, A., Emsley, R., Ashcroft, D. M., Brown, B., & Van Staa, T. (2019). The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care. BMC Med. http://doi.org/10.1186/s12916-019-1368-8
Floyd, J. S., Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., et al. (2019). Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing. PLoS One. http://doi.org/10.1371/journal.pone.0218115
Carr, D. F., Francis, B., Jorgensen, A. L., Zhang, E., Chinoy, H., Heckbert, S. R., et al. (2019). Genome-wide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.1557
Herrett, E., Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., Van Staa, T., et al. (2019). Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study. Lancet. http://doi.org/10.1016/s0140-6736(19)31359-5
Abtahi, S., Burden, A. M., Geusens, P., van den Bergh, J. P., Van Staa, T., & de Vries, F. (2019). The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study. J Am Med Dir Assoc. http://doi.org/10.1016/j.jamda.2019.11.003
Palin, V., Molter, A., Belmonte, M., Ashcroft, D. M., White, A., Welfare, W., & Van Staa, T. (2019). Antibiotic prescribing for common infections in UK general practice: variability and drivers. J Antimicrob Chemother. http://doi.org/10.1093/jac/dkz163
Nowakowska, M., Van Staa, T., Molter, A., Ashcroft, D. M., . Y. Tsang, J., White, A., et al. (2019). Antibiotic choice in UK general practice: rates and drivers of potentially inappropriate antibiotic prescribing. J Antimicrob Chemother. http://doi.org/10.1093/jac/dkz345
Pate, A., Elliott, R. A., Gkountouras, G., Thompson, A., Emsley, R., & Van Staa, T. (2020). The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5023
Pate, A., Emsley, R., Sperrin, M., Martin, G. P., & Van Staa, T. (2020). Impact of sample size on the stability of risk scores from clinical prediction models: a case study in cardiovascular disease. Diagn Progn Res. http://doi.org/10.1186/s41512-020-00082-3
Pate, A., Emsley, R., & Van Staa, T. (2020). Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care. Br J Gen Pract. http://doi.org/10.3399/bjgp20X713057